Japanese Japanese

KBCCC Internatinal Convention 2014

Conference Program

Scientific Program

Day 1: Thursday February 20 12:40 - 18:15
Day 2: Friday February 21 8:00 - 18:15
Day 3: Saturday February 22 8:00 - 13:00

Social Program

Evening Reception - Friday February 21 19:00 - Yamashiro Room
Dress code is kimono or smart casual.

Kimono rental

Poster Presentation

Poster Viewing / Discussion: Friday February 21 8:00 - 9:00
Prize ribbons given to 1st and 2nd place winners: Friday February 21 around noon
Ceremony for Poster Awards: Friday February 21 13:50 - 14:00

PDF Download

PDF  KBCCC 2014 Scientific Program

Scientific Program

Day 1: Thursday February 20
12:40 Opening Remarks
12:45 Session 1: BRCA Mutation and Risk Reduction co-organized with Falco Biosystems
 
Lecture: Breast Cancer Arising in Women with BRCA Mutations (E Winer - USA)
Lecture: BRCA associated increased risk for breast cancer in Newcastle, Australia (J Forbes - Australia)
Lecture: How to deal with hereditary breast and ovarian cancer in the medical practice: Comparison between the USA and Japan (C Tamura - Japan)
Lecture: Risk reducing surgery for BRCA mutation carriers (SW Kim - South Korea)
Moderators: E Winer - USA, H Yamauchi - Japan
14:35 Break. Drinks sponsored by Mars Drinks Japan
14:55 Session 2: Axillary Diagnosis co-organized with Hamamatsu Photonics K.K. and Sysmex Corporation
 
Lecture: Indocyanine green fluorescence imaging system as an alternative to conventional sentinel lymph node mapping using radiotracer in breast cancer. (T Sugie - Japan)
Lecture: The new era of sentinel lymph node biopsy using the One Step Nucleic acid Amplification (OSNA) Assay in Breast Cancer Patients (S Nakamura - Japan)
Lecture: Application of breast ultrasound in axillary staging (CS Huang - Taiwan)
Moderators: J Benson - UK, CS Huang - Taiwan
16:40 Break. Drinks sponsored by Mars Drinks Japan
16:55 Session 3: Axillary Treatment co-organized with Pfizer Japan Inc.
 
Lecture: Axillary Reverse Mapping (ARM) (S Klimberg - USA)
Lecture: Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients (J Benson - UK)
Moderators: L Chow - Hong Kong, S Klimberg - USA
Day 2: Friday February 21
8:00 Poster Viewing / Discussion
9:00 Session 4: Neohormonal Therapy co-organized with Novartis Pharma K.K.
 
Lecture: Recent findings from translational research of neoadjuvant endocrine therapy (AA Larionov - UK)
Lecture: Alternation of biomarkers in breast cancer tissue by neoadjuvant endocrine therapy "Markers of tissue micoenvironment" (H Sasano - Japan)
Lecture: Exploring the host factor affecting endocrine therapy responsiveness using neo-adjuvant therapy trial (S Saji - Japan)
Moderators: S Noguchi - Japan, H Iwata - Japan
10:45 Break. Drinks sponsored by Mars Drinks Japan
11:00 Session 5: Surgical Timing and Neo-HER2 co-organized with Chugai Pharmaceutical Co., Ltd.
 
Lecture: Updates in ERBB2 targeted therapies (M Pegram - USA)
Lecture: Neoadjuvant therapy for HER2-Positive breast cancer (I Krop - USA)
Lecture: Locoregional therapy following neoadjuvant therapy for HER2 positive breast cancer: Opportunities and challenges (S Grobmyer - USA)
Moderators: S Grobmyer - USA, N Masuda - Japan
12:30 Lunch
13:20 Afternoon Seminar co-organized with Daiichi Sankyo Co., Ltd.
 
Lecture: Breast imaging with contrast-enhanced ultrasound (T Ito - Japan)
Moderator: T Kinoshita - Japan
13:50 Poster Awards
14:00 Session 6: Radiation Therapy
 
Lecture: Towards the personalisation of radiotherapy for breast cancer (I Kunkler - UK)
Lecture: Management of the clinically node-negative axilla in primary breast cancer (I Jatoi - USA)
Lecture: The role of radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer (A Ho - USA)
Lecture: Challenges of radiotherapy for breast cancer patients in Japan (N Shikama - Japan)
Moderators: I Kunkler - UK, M Yoshimura - Japan
16:30 Break. Drinks sponsored by Mars Drinks Japan
16:45 Session 7: Triple-Negative Breast Cancer Chemotherapy co-organized with Eisai Co., Ltd.
 
Lecture: Neoadjuvant Chemotherapy – a surgical perspective (tentative) (J Robertson - UK)
Lecture: Recent improvement in neoadjuvant treatment (G von Minckwitz - Germany)
Lecture: The challenge to overcome TNBC heterogenity (H Masuda - Japan)
Moderator: ES Lee - South Korea
Day 3: Saturday February 22
8:00 Session 8: Nomograms and Prediction
 
Lecture: Individualized breast cancer care using nomograms (J Bevilacqua - Brazil)
Lecture: Nomograms to predict positive resection margin and to predict 3 or more positive lymph nodes (W Han - South Korea)
Moderator: M Sugimoto - Japan
9:00 Break. Drinks sponsored by Mars Drinks Japan
9:15 Consensus Session. Light Meal partially sponsored by Shikinoyume
  Chairs: E Winer - USA, J Benson - UK, S Klimberg - USA, M Toi - Japan, T Inamoto - Japan
13:00 Closing Remarks just prior to 13:00 followed by Conference Closure